
Multilateral benefit sharing mechanism for digital sequence ...
Since December 2022, and COP decision 15/9, members of the Convention on Biolog
Newsletters and Deep Dive digital magazine
Since December 2022, and COP decision 15/9, members of the Convention on Biolog
During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) could disrupt this shield.
The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases.
In the realm of medical research, liver disease remains a complex and often overlooked field.
Editor's Picks
Newsletters and Deep Dive
digital magazine